ArticleCancer chemotherapy and pharmacology2024
Correction to: Phase I study of the anti‑TIGIT antibody tiragolumab in combination with atezolizumab in Japanese patients with advanced or metastatic solid tumors.
Noboru Yamamoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.